Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Bullboard (TSX:GUD)

View:
Post by Chianchinon Dec 26, 2022 10:40am

Mugsy and GUD shareholders

Question? Should Mugsy be held laible for promoting GUD to investors beyond the point of investememt logic for ten Years. Mugsy never provided caveat or conditions of concers. Clearly anyone who ...more  
Comment by Chianchinon Dec 24, 2022 2:56pm

RE:2nd Biogen AD drug ...

This is truly relevant to GUD financial disaster 
Post by MrMugsyon Dec 23, 2022 10:44pm

2nd Biogen AD drug ...

Biogen pulled the plug on the first drug. Now they're working on this one ... safety again in question. As enthusiasm mounts for a new experimental antibody that appears to slow cognitive ...more  
Comment by Chianchinon Dec 23, 2022 4:41pm

RE:Shelf Prospectus ...

For ten Years it has been always next Year. Yet nearly one billion in cash badly invested and now borrowing in LATAM depretiating paper. No PP in hard currencies. No buyers to be found for it
Post by MrMugsyon Dec 23, 2022 4:32pm

Shelf Prospectus ...

Comes due in January (I think). Watching for a renewal in Q1. Merry Christmas !!!!
Comment by Chianchinon Dec 23, 2022 11:31am

RE:Ha Ha Ha ... textbook !

The market and investors gets it. you and your aliases do not
Post by MrMugsyon Dec 23, 2022 10:27am

Ha Ha Ha ... textbook !

It's just the way we do it here! All tools available and deployed as it makes sense to do so. You either get it - or you don't ! Happy Holiday's All  !!!!
Post by Chianchinon Dec 23, 2022 7:40am

GUD borrowing?

I had anticipated as only a matter of time. This is what usualy happens when a company burnes good cash nearly 1 billion in 8 years and does not make a profits. What is next?  
Comment by Chianchinon Dec 22, 2022 5:38pm

RE:RE:Here is a repurposing example ...

Well, Mugsy is gone for now. or the scrooge got hold of he/she, the free dinner for mugsy is off the table as no one offered to pitchin. Happy hollydays to all
Comment by Chianchinon Dec 17, 2022 12:42pm

RE:Here is a repurposing example ...

Poor mugsy, lost fortunes for 8 years and still beleives in Paladin lamps and jeene 
Post by MrMugsyon Dec 16, 2022 2:32pm

Here is a repurposing example ...

Won't know the full reasoning behind the Exelon purchase but you start investigating like this ... what kind of drug is Exelon ? Cholinesterase inhibitors (Aricept®, Exelon®, Razadyne ...more  
Comment by EbbFlow88on Dec 16, 2022 2:09pm

RE:RE:RE:RE:Depreciation/Amortization

That's all interesting. I just looked more into ATE. It's not in my wheelhouse or risk tolerance but it can be very interesting piece for knight in the future.  "The other trick ...more  
Comment by MrMugsyon Dec 16, 2022 1:55pm

RE:RE:RE:Depreciation/Amortization

Regarding this comment specifically ... "All things being equal, its a very smart move as we pay less tax but have the cashflow to reinvest. It's also totally legal and conservative of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities